Concepedia

Mark W. Strohsacker

MW

Statistics

Publications

7

Citations

608

H-Index

7

Active since

1982

Affiliations

Howard Hughes Medical Institute(Current)

Duke Medical Center

Duke University Hospital

Molecular Discovery (United Kingdom)

New Frontier

Mark W. Strohsacker is an author at Howard Hughes Medical Institute specializing in biochemistry, life sciences, and receptor pharmacology.

Publications per year

1982–1991

7

Publications

7

Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro

James M. Samanen, F. E. ALI, Todd T. Romoff et al. · Journal of Medicinal Chemistry · 1991 · 193 citations · Full text

, , +11

Isolation and characterization of a cDNA clone encoding rat 5-lipoxygenase.

J M Balcarek, T W Theisen, M. N. Cook et al. · Journal of Biological Chemistry · 1988 · 133 citations · Full text

, , +13

The beta 1-adrenergic receptor of the turkey erythrocyte. Molecular heterogeneity revealed by purification and photoaffinity labeling.

Robert Shorr, Mark W. Strohsacker, T N Lavin et al. · Journal of Biological Chemistry · 1982 · 115 citations · Full text

, , +13

The beta-adrenergic receptor: rapid purification and covalent labeling by photoaffinity crosslinking.

Robert Shorr, Sarah L. Heald, Peter W. Jeffs et al. · Proceedings of the National Academy of Sciences · 1982 · 76 citations · Full text

, , +15

Antibodies to the beta-adrenergic receptor: attenuation of catecholamine-sensitive adenylate cyclase and demonstration of postsynaptic receptor localization in brain.

Catherine D. Strader, Virginia M. Pickel, Tong H. Joh et al. · Proceedings of the National Academy of Sciences · 1983 · 70 citations · Full text

, , +16

1–5 of 7